Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.87 - $1.04 $13 - $16
-16 Reduced 42.11%
22 $0
Q1 2023

May 15, 2023

SELL
$0.91 - $1.23 $1 - $2
-2 Reduced 5.0%
38 $0
Q4 2022

Feb 14, 2023

BUY
$0.8 - $1.12 $14 - $20
18 Added 81.82%
40 $0
Q4 2021

Feb 14, 2022

SELL
$5.81 - $14.39 $871 - $2,158
-150 Reduced 87.21%
22 $0
Q3 2021

Nov 15, 2021

BUY
$11.55 - $20.3 $1,536 - $2,699
133 Added 341.03%
172 $2,000
Q2 2021

Aug 16, 2021

BUY
$17.9 - $23.29 $698 - $908
39 New
39 $1,000

Others Institutions Holding GTH

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.